Acknowledgement
This work was supported by Guangxi Natural Science Foundation (Grant No. 2020GXNSFDA238007).
References
- Widimsky P, Coram R, Abou-Chebl A. Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur Heart J 2014;35:147-55. https://doi.org/10.1093/eurheartj/eht409
- Sharma V, Bell RM, Yellon DM. Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy. Expert Opin Pharmacother 2012;13:1153-75. https://doi.org/10.1517/14656566.2012.685163
- Yang WS, Stockwell BR. Ferroptosis: death by lipid peroxidation. Trends Cell Biol 2016;26:165-76. https://doi.org/10.1016/j.tcb.2015.10.014
- Fan K, Huang W, Qi H, et al. The Egr-1/miR-15a-5p/GPX4 axis regulates ferroptosis in acute myocardial infarction. Eur J Pharmacol 2021;909:174403.
- Zhang M, Zhang Z, Hu J, Zhou S, Ai W. Knockdown of long noncoding RNA MIAT attenuates hypoxia-induced cardiomyocyte injury by regulating the miR-488-3p/Wnt/β-catenin pathway. Cell Biol Int 2023;47:63-74. https://doi.org/10.1002/cbin.11945
- Chen ML, Hong CG, Yue T, et al. Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagy. Theranostics 2021;11:2395-409. https://doi.org/10.7150/thno.47408
- Horvath M, Horvathova V, Hajek P, et al. MicroRNA-331 and microRNA-151-3p as biomarkers in patients with ST-segment elevation myocardial infarction. Sci Rep 2020;10:5845.
- Song X, Shan D, Chen J, Jing Q. miRNAs and lncRNAs in vascular injury and remodeling. Sci China Life Sci 2014;57:826-35. https://doi.org/10.1007/s11427-014-4698-y
- Huang Y. The novel regulatory role of lncRNA-miRNA-mRNA axis in cardiovascular diseases. J Cell Mol Med 2018;22:5768-75. https://doi.org/10.1111/jcmm.13866
- Toischer K, Zhu W, Hunlich M, et al. Cardiomyocyte proliferation prevents failure in pressure overload but not volume overload. J Clin Invest 2017;127:4285-96. https://doi.org/10.1172/JCI81870
- Zhu W, Zhao M, Mattapally S, Chen S, Zhang J. CCND2 overexpression enhances the regenerative potency of human induced pluripotent stem cell-derived cardiomyocytes: remuscularization of injured ventricle. Circ Res 2018;122:88-96. https://doi.org/10.1161/CIRCRESAHA.117.311504
- Ni T, Huang X, Pan S, Lu Z. Inhibition of the long non-coding RNA ZFAS1 attenuates ferroptosis by sponging miR-150-5p and activates CCND2 against diabetic cardiomyopathy. J Cell Mol Med 2021;25:9995-10007. https://doi.org/10.1111/jcmm.16890
- Bai WW, Tang ZY, Shan TC, et al. Up-regulation of paired-related homeobox 2 promotes cardiac fibrosis in mice following myocardial infarction by targeting of Wnt5a. J Cell Mol Med 2020;24:2319-29. https://doi.org/10.1111/jcmm.14914
- Zhou M, Zou YG, Xue YZ, et al. Long non-coding RNA H19 protects acute myocardial infarction through activating autophagy in mice. Eur Rev Med Pharmacol Sci 2018;22:5647-51.
- Zheng HF, Sun J, Zou ZY, Zhang Y, Hou GY. MiRNA-488-3p suppresses acute myocardial infarction-induced cardiomyocyte apoptosis via targeting ZNF791. Eur Rev Med Pharmacol Sci 2019;23:4932-9.
- Castro-Dominguez Y, Dharmarajan K, McNamara RL. Predicting death after acute myocardial infarction. Trends Cardiovasc Med 2018;28:102-9. https://doi.org/10.1016/j.tcm.2017.07.011
- Song Y, Wang B, Zhu X, et al. Human umbilical cord blood-derived MSCs exosome attenuate myocardial injury by inhibiting ferroptosis in acute myocardial infarction mice. Cell Biol Toxicol 2021;37:51-64. https://doi.org/10.1007/s10565-020-09530-8
- Yang J, Huang X, Hu F, Fu X, Jiang Z, Chen K. LncRNA ANRIL knockdown relieves myocardial cell apoptosis in acute myocardial infarction by regulating IL-33/ST2. Cell Cycle 2019;18:3393-403. https://doi.org/10.1080/15384101.2019.1678965
- Hu H, Wu J, Li D, Zhou J, Yu H, Ma L. Knockdown of lncRNA MALAT1 attenuates acute myocardial infarction through miR-320-Pten axis. Biomed Pharmacother 2018;106:738-46. https://doi.org/10.1016/j.biopha.2018.06.122
- Mao C, Wang X, Liu Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res 2018;78:3484-96. https://doi.org/10.1158/0008-5472.CAN-17-3454
- Wei XB, Jiang WQ, Zeng JH, et al. Exosome-derived lncRNA NEAT1 exacerbates sepsis-associated encephalopathy by promoting ferroptosis through regulating miR-9-5p/TFRC and GOT1 axis. Mol Neurobiol 2022;59:1954-69.
- Zhang JK, Zhang Z, Guo ZA, et al. The BMSC-derived exosomal lncRNA Mir9-3hg suppresses cardiomyocyte ferroptosis in ischemia-reperfusion mice via the Pum2/PRDX6 axis. Nutr Metab Cardiovasc Dis 2022;32:515-27. https://doi.org/10.1016/j.numecd.2021.10.017
- Hao X, Wei H. LncRNA H19 alleviates sepsis-induced acute lung injury by regulating the miR-107/TGFBR3 axis. BMC Pulm Med 2022;22:371.
- Song X, Chen Y, Peng Y, et al. LncRNA-PAX8-AS1 silencing decreases cell viability, enhances apoptosis, and suppresses doxorubicin resistance in myeloid leukemia via the miR-378g/ERBB2 axis. Evid Based Complement Alternat Med 2022;2022:2295044.
- Wang S, Liu Y, Hu X, et al. Identification of ceRNA (lncRNA-miRNA-mRNA) regulatory network in myocardial fibrosis after acute myocardial infarction. Int J Gen Med 2021;14:9977-90. https://doi.org/10.2147/IJGM.S329391
- Zhou J, He S, Wang B, et al. Construction and bioinformatics analysis of circRNA-miRNA-mRNA network in acute myocardial infarction. Front Genet 2022;13:854993.
- Gong S, Ying L, Fan Y, Sun Z. Fentanyl inhibits lung cancer viability and invasion via upregulation of miR-331-3p and repression of HDAC5. Onco Targets Ther 2020;13:13131-41. https://doi.org/10.2147/OTT.S281095
- Zhao M, Nakada Y, Wei Y, et al. Cyclin D2 overexpression enhances the efficacy of human induced pluripotent stem cell-derived cardiomyocytes for myocardial repair in a swine model of myocardial infarction. Circulation 2021;144:210-28. https://doi.org/10.1161/CIRCULATIONAHA.120.049497
- Hu Y, Jin G, Li B, et al. Suppression of miRNA let-7i-5p promotes cardiomyocyte proliferation and repairs heart function post injury by targetting CCND2 and E2F2. Clin Sci (Lond) 2019;133:425-41. https://doi.org/10.1042/CS20181002